Evaluation of Sydnone-Based Analogs of Combretastatin A-4 Phosphate (CA4P) as Vascular Disrupting Agents for Use in Cancer Therapy

ChemMedChem - United Kingdom
doi 10.1002/cmdc.201800567
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Cover Feature: Evaluation of Sydnone-Based Analogues of Combretastatin A-4 Phosphate (CA4P) as Vascular Disrupting Agents for Use in Cancer Therapy (ChemMedChem 24/2018)

ChemMedChem
Organic ChemistryMolecular MedicinePharmacologyBiochemistryToxicologyDrug DiscoveryPharmaceutics
2018English

Sydnone Cycloaddition Route to Pyrazole-Based Analogs of Combretastatin A4

Journal of Medicinal Chemistry
Drug DiscoveryMolecular Medicine
2016English

Phase I Trial of Combretastatin A-4 Phosphate With Carboplatin

Clinical Cancer Research
Cancer ResearchOncology
2005English

Vascular Disrupting Agents in Clinical Development

British Journal of Cancer
Cancer ResearchOncology
2007English

Nitric Oxide Synthase Inhibition Enhances the Tumor Vascular-Damaging Effects of Combretastatin A-4 3-O-Phosphate at Clinically Relevant Doses

Clinical Cancer Research
Cancer ResearchOncology
2009English

Isoquinoline-Based Analogs of the Cancer Drug Clinical Candidate Tipifarnib as Anti-Trypanosoma Cruzi Agents

Bioorganic and Medicinal Chemistry Letters
Organic ChemistryMolecular MedicineMolecular BiologyBiochemistryClinical BiochemistryPharmaceutical ScienceDrug Discovery
2009English

Recent Progress on C-4-Modified Podophyllotoxin Analogs as Potent Antitumor Agents

Medicinal Research Reviews
Drug DiscoveryMolecular MedicinePharmacology
2014English

Wharton's Jelly Stem Cells as Agents for Cancer Therapy

The Open Tissue Engineering and Regenerative Medicine Journal
2011English

Evaluation of Novel 4-Thiazolidinone-Based Derivatives as Possible Cytoprotective Agents Against Stress Model in Rats

Journal of Applied Pharmaceutical Science
MedicineToxicologyPharmaceuticsPharmacology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy